Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (321-330 of 341) with videos related to

Pageof 35
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 12, 2025
Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease - an international, multicenter, retrospective cohort studySailish Honap, Maria José Temido, Eathar Shakweh, et al.
The Lancet. Gastroenterology & Hepatology|January 20, 2022
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel DiseasesLucas Guillo, Maria Abreu, Remo Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL ConsensusBénédicte Caron, Maria T Abreu, Corey A Siegel, et al.
Inflammatory Bowel Diseases|November 21, 2013
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohortJohan Burisch, Natalia Pedersen, Silvja Cukovic-Cavka, et al.
Journal of Crohn'S & Colitis|November 12, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical TreatmentJoana Torres, Stefanos Bonovas, Glen Doherty, et al.
Journal of Crohn'S & Colitis|June 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched studyUria Shani, Monica State, Radu Bogdan Mateescu, et al.
European Journal of Gastroenterology & Hepatology|August 23, 2018
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD studyStefania Chetcuti Zammit, Pierre Ellul, Giulia Girardin, et al.
Journal of Crohn'S & Colitis|November 20, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Stefanos Bonovas, Tim Raine, et al.
Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.
Journal of Gastroenterology and Hepatology|December 19, 2018
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD studyJohan Burisch, Stefania Chetcuti Zammit, Pierre Ellul, et al.
Pageof 35

Showing results (321-330 of 341) with videos related to

Sort By:
Pageof 35
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 12, 2025
Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease - an international, multicenter, retrospective cohort studySailish Honap, Maria José Temido, Eathar Shakweh, et al.
The Lancet. Gastroenterology & Hepatology|January 20, 2022
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel DiseasesLucas Guillo, Maria Abreu, Remo Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL ConsensusBénédicte Caron, Maria T Abreu, Corey A Siegel, et al.
Inflammatory Bowel Diseases|November 21, 2013
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohortJohan Burisch, Natalia Pedersen, Silvja Cukovic-Cavka, et al.
Journal of Crohn'S & Colitis|November 12, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical TreatmentJoana Torres, Stefanos Bonovas, Glen Doherty, et al.
Journal of Crohn'S & Colitis|June 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched studyUria Shani, Monica State, Radu Bogdan Mateescu, et al.
European Journal of Gastroenterology & Hepatology|August 23, 2018
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD studyStefania Chetcuti Zammit, Pierre Ellul, Giulia Girardin, et al.
Journal of Crohn'S & Colitis|November 20, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Stefanos Bonovas, Tim Raine, et al.
Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.
Journal of Gastroenterology and Hepatology|December 19, 2018
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD studyJohan Burisch, Stefania Chetcuti Zammit, Pierre Ellul, et al.
Pageof 35